Lineage Cell Therapeutics Inc (LCTX)

[DeepDive]

I tend to agree with most of your speculation except I fear you may be a bit too optimistic about a speedy path to approval.

It should be extremely clear and I have always stated that BTX and its Subs are NO WAY NEAR revenue or approval.

It is understood that investors in this business understand and agree that Cash Flows from products are years away.

It may NOT be the proper investment to a retiree for that reason alone.

Having said that, surges in market cap usually precede cash flows form products.

With the above in mind, of all the various therapies developed, Renevia, OpRegen and Oncocyte's test are the closest to approval and therefore the closest catalysts (again, it will take at least 2 years to see Rev, and even after approval, we would need time to market and get acceptance. Renevia will lead the way.)

I believe this speculative for now investment will become a mainstream business in 10 years, but I reserve the right to be wrong and my position is accordingly.